Skip to main content
Fig. 4 | Breast Cancer Research

Fig. 4

From: Multimodal prediction of neoadjuvant treatment outcome by serial FDG PET and MRI in women with locally advanced breast cancer

Fig. 4

Kaplan–Meier analysis for recurrence-free survival (RFS). Shown are Kaplan–Meier curves stratified by A RCB status and mid-treatment percentage change from baseline in B K1, C MRFDG, D washout volume, E peak SER, and F MRFDG/ peak SER. For B–F, patients were dichotomized at the third quartile for each imaging metric. Patients achieving RCB 0/I tended to exhibit longer RFS versus those with RCB II/III, but the difference did not reach significance (p = 0.07). Patients with larger decreases (blue) in K1, MRFDG, washout volume, peak SER and MRFDG/peak SER ratio showed longer RFS (p < 0.05) compared to those with smaller decreases. Kaplan–Meier curves were compared using the log-rank test

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us